Edgewise Therapeutics, Inc. (EWTX)
44.22
-0.50
(-1.12%)
USD |
NASDAQ |
Aug 25, 16:00
44.22
0.00 (0.00%)
After-Hours: 17:15
Edgewise Therapeutics 1 Year Total Returns (Daily) : 201.1% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 201.1% |
| August 21, 2026 | 202.2% |
| August 20, 2026 | 212.8% |
| August 19, 2026 | 236.5% |
| August 18, 2026 | 215.1% |
| August 17, 2026 | 211.2% |
| August 14, 2026 | 217.1% |
| August 13, 2026 | 214.5% |
| August 12, 2026 | 225.3% |
| August 11, 2026 | 241.1% |
| August 10, 2026 | 251.6% |
| August 07, 2026 | 236.1% |
| August 06, 2026 | 228.7% |
| August 05, 2026 | 227.4% |
| August 04, 2026 | 228.5% |
| August 03, 2026 | 168.2% |
| July 31, 2026 | 169.5% |
| July 30, 2026 | 189.0% |
| July 29, 2026 | 184.9% |
| July 28, 2026 | 183.0% |
| July 27, 2026 | 194.6% |
| July 24, 2026 | 179.2% |
| July 23, 2026 | 173.0% |
| July 22, 2026 | 183.1% |
| July 21, 2026 | 195.6% |
| Date | Value |
|---|---|
| July 20, 2026 | 186.6% |
| July 17, 2026 | 189.6% |
| July 16, 2026 | 180.0% |
| July 15, 2026 | 205.2% |
| July 14, 2026 | 185.2% |
| July 13, 2026 | 198.2% |
| July 10, 2026 | 227.4% |
| July 09, 2026 | 243.2% |
| July 08, 2026 | 255.6% |
| July 07, 2026 | 242.0% |
| July 06, 2026 | 207.8% |
| July 02, 2026 | 204.1% |
| July 01, 2026 | 205.4% |
| June 30, 2026 | 209.9% |
| June 29, 2026 | 210.7% |
| June 26, 2026 | 217.5% |
| June 25, 2026 | 190.9% |
| June 24, 2026 | 186.8% |
| June 23, 2026 | 173.8% |
| June 22, 2026 | 155.2% |
| June 18, 2026 | 154.4% |
| June 17, 2026 | 140.3% |
| June 16, 2026 | 131.3% |
| June 15, 2026 | 130.3% |
| June 12, 2026 | 125.9% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Cocrystal Pharma, Inc. | -29.14% |
| CNBX Pharmaceuticals, Inc. | -75.00% |
| GB Sciences, Inc. | 50.00% |
| Arvinas, Inc. | 27.60% |
| Fulcrum Therapeutics, Inc. | -44.19% |